Scott Braunstein

Scott Braunstein

Chief Executive Officer at MARINUS PHARMACEUTICALS, INC.

Net worth: 2 M $ as of 2024-03-30

60 year
Health Technology
Finance
Consumer Services

Profile

Scott N.
Braunstein
is currently the Chairman, President & Chief Executive Officer at Marinus Pharmaceuticals, Inc. He is also an Independent Director at Caribou Biosciences, Inc., the Lead Independent Director at Trevena, Inc., a Director at SiteOne Therapeutics, Inc., and a Director at Cornell University College of Agriculture & Life Sciences, BWBC I LLC, and Bent Water Brewing Corp.
Additionally, he serves as an Operating Partner at Aisling Capital LLC.
In his former roles, Braunstein served as the Chairman of ArTara Subsidiary, Inc. He was also a Managing Director at JPMorgan Investment Management, Inc. from 2002 to 2014.
He served as an Independent Director at Esperion Therapeutics, Inc. from 2015 to 2020.
Braunstein was a Managing Director & Senior Portfolio Manager at JPMorgan Chase & Co. from 2002 to 2014.
He also served as a Director at Alaunos Therapeutics, Inc. from 2018 to 2020, Constellation Pharmaceuticals, Inc. from 2019 to 2021, and Protara Therapeutics, Inc. from 2018 to 2020.
Additionally, he was a Principal at Deutsche Bank AG from 2000 to 2002 and Vice President-Operations at Cello Health BioConsulting Inc. from 1999 to 2000.
Braunstein served as the Chief Operating Officer at Pacira Biosciences, Inc. from 2017 to 2018 and was a Portfolio Manager at EverPoint Asset Management LLC from 2014 to 2015.
He also worked as a Physician at Summit Medical Group LLC and was a Portfolio Manager at JPMorgan Global Healthcare Fund.
Braunstein received his undergraduate degree from Cornell University in 1986 and his doctorate degree from Albert Einstein College of Medicine, Inc. in 1990.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-26 273,512 ( 0.50% ) 2 M $ 2024-03-30
2024-02-08 0 ( -.--% ) - $ 2024-03-30
2024-02-19 0 ( -.--% ) - $ 2024-03-30

Scott Braunstein active positions

CompaniesPositionStart
MARINUS PHARMACEUTICALS, INC. Chief Executive Officer 2019-08-11
TREVENA, INC. Director/Board Member 2018-08-31
CARIBOU BIOSCIENCES, INC. Director/Board Member 2021-05-31
Private Equity Investor 2015-08-31
Director/Board Member -
Director/Board Member -
Director/Board Member 2018-09-10
Chief Operating Officer 2009-12-31
Cornell University College of Agriculture & Life Sciences Director/Board Member -
All active positions of Scott Braunstein

Former positions of Scott Braunstein

CompaniesPositionEnd
░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ -
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of Scott Braunstein's experience

Training of Scott Braunstein

Cornell University Undergraduate Degree
Albert Einstein College of Medicine, Inc. Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Scott Braunstein's experience

Connections

100 +

1st degree connections

25

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies8
DEUTSCHE BANK AG

Finance

ESPERION THERAPEUTICS, INC.

Health Technology

JPMORGAN CHASE & CO.

Finance

MARINUS PHARMACEUTICALS, INC.

Health Technology

PACIRA BIOSCIENCES, INC.

Health Technology

ALAUNOS THERAPEUTICS, INC.

Health Technology

TREVENA, INC.

Health Technology

PROTARA THERAPEUTICS, INC.

Health Technology

Private companies13

Finance

Finance

Commercial Services

Caribou Biosciences, Inc.

JPMorgan Global Healthcare Fund

Miscellaneous

Commercial Services

Health Technology

Finance

Health Technology

Health Services

Health Technology

Consumer Non-Durables

Consumer Non-Durables

See company connections
  1. Stock Market
  2. Insiders
  3. Scott Braunstein